Publications by Stein O. Kvaløy
139 publications found
Original articles
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life
Haematologica, 107 (11), 2698-2707
DOI 10.3324/haematol.2021.280413, PubMed 35484681
Factors influencing access to palliative radiotherapy: a Norwegian population-based study
Acta Oncol, 57 (9), 1250-1258
DOI 10.1080/0284186X.2018.1468087, PubMed 29706109
Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
Acta Oncol, 57 (6), 773-781
DOI 10.1080/0284186X.2017.1406137, PubMed 29171324
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
Clin Microbiol Infect, 23 (3), 179-187
DOI 10.1016/j.cmi.2016.10.019, PubMed 27793737
Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation
Br J Cancer, 115 (2), 178-87
DOI 10.1038/bjc.2016.180, PubMed 27351215
Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation
Acta Oncol, 55 (5), 547-53
DOI 10.3109/0284186X.2015.1125015, PubMed 27123741
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma
Br J Haematol, 173 (3), 432-43
DOI 10.1111/bjh.13965, PubMed 26914167
Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study
J Clin Oncol, 33 (24), 2683-91
DOI 10.1200/JCO.2015.60.8125, PubMed 26169610
Utilization of radiation therapy in Norway after the implementation of the national cancer plan--a national, population-based study
Int J Radiat Oncol Biol Phys, 90 (3), 707-14
DOI 10.1016/j.ijrobp.2014.06.059, PubMed 25160610
Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma
Acta Oncol, 53 (5), 680-7
DOI 10.3109/0284186X.2013.855816, PubMed 24237392
Atherosclerotic lesions in lymphoma survivors treated with radiotherapy
Radiother Oncol, 110 (3), 448-54
DOI 10.1016/j.radonc.2013.10.029, PubMed 24231235
High-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment
Tidsskr Nor Laegeforen, 133 (16), 1735-9
DOI 10.4045/tidsskr.13.0319, PubMed 24005713
High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008
Tidsskr Nor Laegeforen, 133 (16), 1704-9
DOI 10.4045/tidsskr.13.0243, PubMed 24005706
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
Scand J Immunol, 74 (6), 632-9
DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Lancet Oncol, 12 (11), 1013-22
DOI 10.1016/S1470-2045(11)70235-2, PubMed 21940214
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment
Bone Marrow Transplant, 46 (1), 44-51
DOI 10.1038/bmt.2010.84, PubMed 20436517
Pain after palliative radiotherapy for spine metastases
Clin Oncol (R Coll Radiol), 22 (10), 828-36
DOI 10.1016/j.clon.2010.03.008, PubMed 20363110
Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
J Am Med Inform Assoc, 17 (4), 403-10
DOI 10.1136/jamia.2010.005660, PubMed 20595307
[Use of radiotherapy in South-Eastern Norway Regional Health Authority]
Tidsskr Nor Laegeforen, 129 (24), 2602-5
DOI 10.4045/tidsskr.09.0331, PubMed 20029555
A population-based study of spinal metastatic disease in South-East Norway
Clin Oncol (R Coll Radiol), 21 (10), 753-9
DOI 10.1016/j.clon.2009.09.023, PubMed 19850454
Stromal gene signatures in large-B-cell lymphomas
N Engl J Med, 359 (22), 2313-23
DOI 10.1056/NEJMoa0802885, PubMed 19038878
[Courses for cancer patients--15 years' experience at The Montebello Centre in Norway]
Tidsskr Nor Laegeforen, 128 (22), 2554-7
PubMed 19023349
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
Lancet Oncol, 9 (5), 435-44
DOI 10.1016/S1470-2045(08)70078-0, PubMed 18400558
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
Ann Oncol, 18 (6), 1085-9
DOI 10.1093/annonc/mdm073, PubMed 17363838
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
J Antimicrob Chemother, 59 (4), 711-7
DOI 10.1093/jac/dkm003, PubMed 17327294
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Blood, 109 (11), 4599-606
DOI 10.1182/blood-2006-08-039859, PubMed 17299095
Molecular diagnosis of Burkitt's lymphoma
N Engl J Med, 354 (23), 2431-42
DOI 10.1056/NEJMoa055759, PubMed 16760443
Vitamin D deficiency in patients operated on for gastric lymphoma
Scand J Gastroenterol, 41 (6), 673-81
DOI 10.1080/00365520500356510, PubMed 16716965
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Lancet Oncol, 7 (5), 379-91
DOI 10.1016/S1470-2045(06)70664-7, PubMed 16648042
Quality of life after total or partial gastrectomy for primary gastric lymphoma
Acta Oncol, 45 (2), 202-9
DOI 10.1080/02841860500492067, PubMed 16546867
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
Blood, 106 (9), 3183-90
DOI 10.1182/blood-2005-04-1399, PubMed 16046532
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
J Pathol, 206 (3), 312-9
DOI 10.1002/path.1777, PubMed 15892171
Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
Bone Marrow Transplant, 35 (12), 1149-53
DOI 10.1038/sj.bmt.1704988, PubMed 15880133
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
Tidsskr Nor Laegeforen, 125 (1), 41-4
PubMed 15643464
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
N Engl J Med, 351 (21), 2159-69
DOI 10.1056/NEJMoa041869, PubMed 15548776
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience
Eur J Haematol, 73 (3), 179-82
DOI 10.1111/j.1600-0609.2004.00294.x, PubMed 15287915
Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens
Ann Oncol, 15 (7), 1072-8
DOI 10.1093/annonc/mdh262, PubMed 15205201
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy
Br J Haematol, 125 (5), 605-12
DOI 10.1111/j.1365-2141.2004.04951.x, PubMed 15147376
Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study
Ann Hematol, 83 (7), 414-9
DOI 10.1007/s00277-004-0855-x, PubMed 15085385
The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation
Psychooncology, 12 (8), 803-13
DOI 10.1002/pon.708, PubMed 14681953
High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial
J Clin Oncol, 21 (21), 3918-27
DOI 10.1200/JCO.2003.10.023, PubMed 14517188
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
J Exp Med, 198 (6), 851-62
DOI 10.1084/jem.20031074, PubMed 12975453
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Cancer Cell, 3 (2), 185-97
DOI 10.1016/s1535-6108(03)00028-x, PubMed 12620412
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study
Clin Cancer Res, 9 (2), 722-8
PubMed 12576441
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
Blood, 101 (10), 3840-8
DOI 10.1182/blood-2002-10-3238, PubMed 12531794
Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time
Ann Oncol, 13 (11), 1786-91
DOI 10.1093/annonc/mdf289, PubMed 12419752
Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model
Ann Oncol, 13 (7), 1099-107
DOI 10.1093/annonc/mdf175, PubMed 12176790
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
N Engl J Med, 346 (25), 1937-47
DOI 10.1056/NEJMoa012914, PubMed 12075054
[Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma]
Tidsskr Nor Laegeforen, 122 (4), 364-9
PubMed 11915663
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
Bone Marrow Transplant, 28 (9), 849-57
DOI 10.1038/sj.bmt.1703244, PubMed 11781645
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines
Bone Marrow Transplant, 28 (7), 681-7
DOI 10.1038/sj.bmt.1703228, PubMed 11704791
[The radiotherapy satellite in Kristiansand--a model for Norwegian regional hospitals?]
Tidsskr Nor Laegeforen, 121 (18), 2179-82
PubMed 11571996
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients
Eur J Haematol Suppl, 64, 14-20
PubMed 11486395
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients
Eur. J. Haematol., 66 64, 14-20
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group
J Clin Oncol, 19 (11), 2927-36
DOI 10.1200/JCO.2001.19.11.2927, PubMed 11387366
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas
Bone Marrow Transplant, 27 (7), 711-6
DOI 10.1038/sj.bmt.1702867, PubMed 11360110
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial
Med Oncol, 18 (1), 85-94
DOI 10.1385/MO:18:1:85, PubMed 11778974
CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD
Cytotherapy, 3 (4), 295-305
DOI 10.1080/146532401317070934, PubMed 12171718
Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis
Eur J Cancer, 36 (14), 1762-8
DOI 10.1016/s0959-8049(00)00171-4, PubMed 10974623
High level of fatigue in lymphoma patients treated with high dose therapy
J Pain Symptom Manage, 19 (6), 446-56
DOI 10.1016/s0885-3924(00)00144-5, PubMed 10908825
The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)
Ann Oncol, 11 Suppl 1, 91-4
PubMed 10707787
Stage I high-grade non-Hodgkin's lymphoma
Acta Oncol, 39 (7), 865-72
DOI 10.1080/028418600750063631, PubMed 11145446
The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation
Bone Marrow Transplant, 24 (11), 1219-28
DOI 10.1038/sj.bmt.1702046, PubMed 10642812
High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma
Bone Marrow Transplant, 24 (8), 865-72
DOI 10.1038/sj.bmt.1701990, PubMed 10516698
Persistent changes in the immune system 4-10 years after ABMT
Bone Marrow Transplant, 24 (8), 873-8
DOI 10.1038/sj.bmt.1702006, PubMed 10516699
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial
Ann Oncol, 10 (9), 1079-86
DOI 10.1023/a:1008392528248, PubMed 10572606
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study
J Clin Oncol, 17 (2), 706-18
DOI 10.1200/JCO.1999.17.2.706, PubMed 10080617
Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers
Acta Oncol, 38 (4), 495-503
DOI 10.1080/028418699432040, PubMed 10418718
Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease
Acta Oncol, 38 (4), 511-5
DOI 10.1080/028418699432068, PubMed 10418720
[Primary non-Hodgkin's lymphoma of the brain]
Tidsskr Nor Laegeforen, 118 (29), 4524-6
PubMed 9889638
Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution
Eur J Cancer, 34 (12), 1865-70
DOI 10.1016/s0959-8049(98)00269-x, PubMed 10023307
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas
Br J Cancer, 77 (11), 1839-41
DOI 10.1038/bjc.1998.305, PubMed 9667655
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma
Bone Marrow Transplant, 21 (9), 873-8
DOI 10.1038/sj.bmt.1701192, PubMed 9613778
Hodgkin's disease in a national and hospital population: trends over 20 years
Eur J Cancer, 33 (14), 2380-3
DOI 10.1016/s0959-8049(97)00342-0, PubMed 9616285
Bone-marrow MR imaging before and after autologous marrow transplantation in lymphoma patients without known bone-marrow involvement
Acta Radiol, 38 (5), 896-902
DOI 10.1080/02841859709172432, PubMed 9332252
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
Br J Haematol, 98 (3), 711-8
DOI 10.1046/j.1365-2141.1997.2473063.x, PubMed 9332329
[Check up of breast cancer stages 1 and 2]
Tidsskr Nor Laegeforen, 117 (8), 1079-81
PubMed 9148472
Immunomagnetic purging of lymphoma cells from autografts
J Hematother, 5 (5), 561-2
DOI 10.1089/scd.1.1996.5.561, PubMed 8938530
[High-dose therapy with autologous stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic stem cells isolate from blood]
Tidsskr Nor Laegeforen, 116 (21), 2547-51
PubMed 8928122
[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services]
Tidsskr Nor Laegeforen, 116 (21), 2577-81
PubMed 8928130
[High-dose therapy of cancer with CD34 positive cells as stem cell support]
Tidsskr Nor Laegeforen, 116 (21), 2542-6
PubMed 8928121
Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma
Bone Marrow Transplant, 17 (4), 577-81
PubMed 8722358
Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institution
Ann Oncol, 7 (2), 145-50
DOI 10.1093/oxfordjournals.annonc.a010541, PubMed 8777170
Prognostic variables and results of salvage treatment in Hodgkin's disease
Acta Oncol, 35 Suppl 8, 67-72
DOI 10.3109/02841869609098522, PubMed 9073050
[Quality assurance in health care--a paper tiger?]
Tidsskr Nor Laegeforen, 115 (26), 3235-6
PubMed 7482449
GA-67 SCINTIGRAPHY, MRI AND CT IN THE FOLLOW-UP OF MALIGNANT-LYMPHOMA PATIENTS WITH RESIDUAL MEDIASTINAL MASS
ADV PHAR SC, 51-56
Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study
Ann Oncol, 5 (5), 433-6
DOI 10.1093/oxfordjournals.annonc.a058875, PubMed 8075050
[Bone marrow transplantation--a constantly developing procedure--requiring updating]
Tidsskr Nor Laegeforen, 114 (3), 302-3
PubMed 8191422
[New cancer disease after treatment of Hodgkin's disease]
Tidsskr Nor Laegeforen, 113 (23), 2903-5
PubMed 8236191
[Hodgkin's disease or lymphogranulomatosis. New views on prognosis, complicating conditions and complications after treatment]
Tidsskr Nor Laegeforen, 113 (23), 2899-903
PubMed 8236190
Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas
Br J Haematol, 83 (3), 392-8
DOI 10.1111/j.1365-2141.1993.tb04662.x, PubMed 8097923
Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age
J Clin Oncol, 11 (2), 255-61
DOI 10.1200/JCO.1993.11.2.255, PubMed 8426202
Follow-up of breast cancer patients stage I-II: a baseline strategy
Eur J Cancer, 29A (7), 992-7
DOI 10.1016/s0959-8049(05)80208-4, PubMed 8098950
[Infection problems in the leukopenia phase after autologous bone marrow transplantation]
Tidsskr Nor Laegeforen, 112 (13), 1723-6
PubMed 1509434
An effective immunomagnetic method for bone marrow purging in T cell malignancies
Bone Marrow Transplant, 9 (5), 319-23
PubMed 1617315
Bone marrow examination in Hodgkin's disease
Acta Oncol, 31 (1), 41-2
DOI 10.3109/02841869209088263, PubMed 1586503
[Tumor lysis syndrome. A life-threatening complication during cytostatic treatment of chemosensitive types of cancer]
Tidsskr Nor Laegeforen, 111 (19), 2435-7
PubMed 1926084
[Non-Hodgkin's lymphoma in the gastrointestinal tract]
Tidsskr Nor Laegeforen, 111 (1), 59-60
PubMed 2000590
[Diagnosis and treatment of solitary plasmacytoma]
Tidsskr Nor Laegeforen, 110 (12), 1515-6
PubMed 2339400
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group
Eur J Cancer, 26 (3), 311-4
DOI 10.1016/0277-5379(90)90227-k, PubMed 2141487
Extramedullary plasmacytomas and solitary plasma cell tumours of bone
Eur J Haematol, 44 (2), 132-5
DOI 10.1111/j.1600-0609.1990.tb00364.x, PubMed 2318296
EXTRAMEDULLARY PLASMACYTOMAS AND SOLITARY PLASMA-CELL TUMORS OF BONE
Eur. J. Haematol., 44 (2), 131-134
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma
Int J Cancer, 44 (6), 975-80
DOI 10.1002/ijc.2910440605, PubMed 2606582
[Giant cell anaplastic anemia]
Tidsskr Nor Laegeforen, 109 (23), 2289-94
PubMed 2772896
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation
J Natl Cancer Inst, 80 (16), 1322-5
DOI 10.1093/jnci/80.16.1322, PubMed 3050139
The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas
Int J Cancer, 39 (5), 590-4
DOI 10.1002/ijc.2910390508, PubMed 3106247
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial
Eur J Cancer Clin Oncol, 22 (12), 1431-4
DOI 10.1016/0277-5379(86)90075-1, PubMed 3595668
[Monoclonal antibodies. A new tool in the diagnosis of leukemia and lymphoma]
Tidsskr Nor Laegeforen, 105 (22), 1379-82
PubMed 4049331
Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement receptor--their relationship to survival
Scand J Haematol, 35 (2), 137-44
DOI 10.1111/j.1600-0609.1985.tb01562.x, PubMed 3876595
3H-thymidine uptake in B cell lymphomas--relationship to treatment response and survival
Scand J Haematol, 34 (5), 429-35
DOI 10.1111/j.1600-0609.1985.tb00773.x, PubMed 3925545
THYMIDINE-H-3 UPTAKE IN B-CELL LYMPHOMAS - RELATIONSHIP TO TREATMENT RESPONSE AND SURVIVAL
SCAND J HAEMATOL, 34 (5), 429-435
Immunoblastic lymphadenopathy with early onset in two boys: immunohistochemical study and indication of decreased proportion of circulating T-helper cells
Br J Haematol, 56 (3), 417-30
DOI 10.1111/j.1365-2141.1984.tb03972.x, PubMed 6230099
Transferrin receptor and B-lymphoblast antigen--their relationship to DNA synthesis, histology and survival in B-cell lymphomas
Int J Cancer, 33 (2), 173-7
DOI 10.1002/ijc.2910330204, PubMed 6319299
[Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer]
Tidsskr Nor Laegeforen, 103 (27), 1873-5
PubMed 6359581
Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development
J Clin Immunol, 3 (3), 212-21
DOI 10.1007/BF00915345, PubMed 6604064
SOLITARY PLASMACYTOMAS OF BONE
SCAND J HAEMATOL, 30 39, 23-29
Distribution of T-cell subsets identified by monoclonal antibodies in cell suspensions from lymph node biopsies of human B-cell lymphomas
Scand J Haematol, 28 (4), 293-305
DOI 10.1111/j.1600-0609.1982.tb00530.x, PubMed 6981200
Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies
Differentiation, 22 (2), 113-9
DOI 10.1111/j.1432-0436.1982.tb01234.x, PubMed 6290303
Spontaneous (H)-thymidine uptake in histological subgroups of human B-cell lymphomas
Scand J Haematol, 26 (3), 221-34
DOI 10.1111/j.1600-0609.1981.tb01650.x, PubMed 7015478
Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry
Acta Pathol Microbiol Scand A, 89 (2), 91-101
PubMed 7023187
[Antibody synthesis biology. A theme with variations--from amino acid sequence and regulatory cell circuits to malignant lymphomas]
Tidsskr Nor Laegeforen, 100 (19-21), 1214-8
PubMed 6968461
MAN, NATURE AND MECHANISTIC SYSTEMS - AN EXERCISE IN ECOPHILOSOPHY
ALTERNATIVE FUTURES, 3 (3), 32-46
Cellular antitumor immune response in women with risk factors for breast cancer
Cancer Res, 39 (2 Pt 2), 654-7
PubMed 761231
[Tissue necrosis caused by careless injection of cytostatic agents]
Tidsskr Nor Laegeforen, 98 (27), 1330-1
PubMed 694872
Review articles
The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review
Acta Oncol, 51 (4), 433-40
DOI 10.3109/0284186X.2011.633931, PubMed 22175253
[Molecular diagnosis of malignant lymphomas]
Tidsskr Nor Laegeforen, 129 (22), 2352-6
DOI 10.4045/tidsskr.09.0704, PubMed 19935935
[Penicillin and aminoglycoside in febrile neutropenia]
Tidsskr Nor Laegeforen, 128 (23), 2738-40
PubMed 19079423
[The importance of nutrition for cancer patients]
Tidsskr Nor Laegeforen, 118 (22), 3466-70
PubMed 9800498
Purging of tumor cells from leukapheresis products: experimental and clinical aspects
J Hematother, 5 (4), 427-36
DOI 10.1089/scd.1.1996.5.427, PubMed 8877718
Other articles
Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
Bone Marrow Transplant, 52 (4), 646-649
DOI 10.1038/bmt.2016.338, PubMed 27991891
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway
Haematologica, 100 (6), e240-3
DOI 10.3324/haematol.2014.119214, PubMed 25682605
[Norwegian program for malignant lymphomas]
Tidsskr Nor Laegeforen, 123 (7), 914
PubMed 12737057
Testicular lymphoma is associated with a high risk of extranodal recurrence
Cancer, 89 (3), 713-4
PubMed 10931479
Influence of progestogen therapy on T lymphocyte subsets
Acta Pathol Microbiol Immunol Scand C, 92 (1), 89-91
DOI 10.1111/j.1699-0463.1984.tb00057.x, PubMed 6608858
Books
Kostråd til kreftpasienter: informasjon til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 6/2001 (6. oppl.), 48 s.
BIBSYS 022497749
Høydosebehandling med autolog stamcellestøtte ved malignelidelser: innstilling
In Utredningsserie, Tilsynet, Oslo, 1-95, 85 s.
BIBSYS 952074257
Book chapters
Medikamentell kreftbehandling
In Cytostatikaboken 7. utgave 2009 (Dahl O, Lehne G, Baksaas I, Kvaløy S, Christoffersen T, eds.), Farmakologisk Institutt, Universitetet i Oslo, Oslo, Norge
PublikaID 77, ISBN 9788299233125
Medikamentell kreftbehandling
In Cytostatikaboken. 7. utgave (Dahl O, Kvaløy SO, Lehne G, Baksaas I, Christoffersen T, eds.), Farmakologisk institutt, Universitetet i Oslo, Oslo
PublikaID 88
Theses
Phenotypic and functional properties of B cell neoplasms with reference to clinical characteristics
Norwegian Cancer Society, Oslo, 1 b. (flere pag.)
BIBSYS 861035615, ISBN 82-90187-15-7